Search clinical trials for: Brentuximab vedotin (SGN-35)
Total 188 results
-
Memorial Sloan Kettering Cancer CenterSeagen Inc.; Hôpitaux Universitaires Henri Mondor, FranceCompletedHodgkin's LymphomaUnited States
-
Fondazione Italiana Linfomi ONLUSCompletedRelapsed/Refractory Hodgkin's LymphomaItaly
-
Seagen Inc.CompletedLymphoma, Non-Hodgkin | Lymphoma, Large-Cell, Anaplastic | Disease, HodgkinUnited States
-
Seagen Inc.Millennium Pharmaceuticals, Inc.No longer availableLymphoma, Non-Hodgkin | Lymphoma, T-Cell, Cutaneous | Lymphoma, Large-Cell, Anaplastic | Disease, HodgkinUnited States, United Kingdom, Belgium, Serbia, Australia, Bulgaria, France, Germany, Hungary, Italy, Poland, Romania, Russian Federation, Spain, Switzerland
-
Seagen Inc.Millennium Pharmaceuticals, Inc.CompletedLymphoma, Non-Hodgkin | Lymphoma, Large-Cell, Anaplastic | Disease, HodgkinUnited States, Germany
-
Seagen Inc.Millennium Pharmaceuticals, Inc.CompletedDisease, HodgkinUnited States, France, Canada, Belgium, Italy
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed or Refractory Hodgkin Lymphoma | Relapsed or Refractory Anaplastic Large-cell LymphomaUnited States, France, United Kingdom, Germany, Spain, Netherlands, Italy, Mexico
-
Seagen Inc.Millennium Pharmaceuticals, Inc.CompletedLymphoma, Non-Hodgkin | Lymphoma, Large-Cell, AnaplasticUnited States, France, Canada, Belgium, United Kingdom
-
Youn KimSeagen Inc.CompletedMycosis Fungoides | Sezary Syndrome | Cutaneous T-cell Lymphoma (CTCL) | Cutaneous Lymphoma | Non-Hodgkin Lymphoma (NHL)United States
-
UNC Lineberger Comprehensive Cancer CenterSeagen Inc.CompletedHodgkin Lymphoma, AdultUnited States
-
Seagen Inc.Millennium Pharmaceuticals, Inc.CompletedDisease, HodgkinUnited States, United Kingdom, France, Romania, Poland, Italy, Bulgaria, Hungary, Russian Federation, Czechia, Spain, Germany, Serbia
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States
-
Nabil AdraTerminatedNonseminomatous Germ Cell Tumor | Testis Cancer | Testicular Cancer | Embryonal Carcinoma | Germ Cell TumorsUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Seagen Inc.Completed
-
M.D. Anderson Cancer CenterTerminated
-
Fondazione MichelangeloFondazione IRCCS Istituto Nazionale dei Tumori, Milano; Millennium Pharmaceuticals...CompletedGerm Cell CancerItaly
-
University of Kansas Medical CenterSeagen Inc.Recruiting
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Seagen Inc.WithdrawnHematopoietic/Lymphoid CancerUnited States
-
M.D. Anderson Cancer CenterSeagen Inc.Active, not recruitingLymphoma | Mycosis Fungoides | Lymphoma, Primary Cutaneous Anaplastic Large Cell | CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma | Lymphomatoid Papulosis | Skin Lymphoma | Cutaneous Lymphomas | Hematologic DisorderUnited States
-
TakedaActive, not recruiting
-
Fred Hutchinson Cancer Research Center/University...National Cancer Institute (NCI)WithdrawnGraft Versus Host DiseaseUnited States
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingLymphomaBelgium, Spain, Czechia, Hungary, Croatia, Portugal, Turkey, Poland, United Kingdom, Romania
-
M.D. Anderson Cancer CenterSeagen Inc.Recruiting
-
Millennium Pharmaceuticals, Inc.CompletedHodgkin LymphomaPoland, Spain, Malaysia, Turkey, Germany, Czechia, Thailand
-
Fondazione Italiana Linfomi ONLUSCompletedPrimary Mediastinal Large B Cell LymphomaItaly
-
Seagen Inc.TerminatedHodgkin Lymphoma | Anaplastic Large Cell Lymphoma | Peripheral T Cell LymphomaUnited States
-
Seagen Inc.CompletedAcute Myeloid Leukemia | Solid Tumors | Acute Lymphoid Leukemia | Anemia, Refractory, With Excess of BlastsUnited States
-
Northwestern UniversitySeagen Inc.TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Immunoblastic Large Cell... and other conditionsUnited States
-
Seagen Inc.CompletedLymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Lymphoma, T-CellUnited States, Canada
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Genentech, Inc.TerminatedLymphomaUnited States
-
Seagen Inc.Bristol-Myers SquibbCompletedHodgkin LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterMethylGene Inc.CompletedHodgkin LymphomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteSeagen Inc.Withdrawn
-
Seagen Inc.CompletedHodgkin DiseaseUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMalignant Mesothelioma | CD30-Positive Neoplastic Cells PresentUnited States
-
Jason Robert GotlibSeagen Inc.CompletedSystemic Mastocytosis | Mast Cell Leukemia | Aggressive Systemic MastocytosisUnited States
-
Lawson Health Research InstituteSeagen Inc.RecruitingDiffuse Cutaneous Systemic SclerosisCanada
-
H. Lee Moffitt Cancer Center and Research InstituteSeagen Inc.TerminatedPilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30Peripheral T-Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterTakedaWithdrawnAnaplastic Large Cell Lymphoma | Classical Hodgkin Lymphoma | Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic | CD30+ Peripheral T-cell Lymphoma
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Seagen Inc.WithdrawnBrentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell LymphomaRecurrent Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified | Recurrent Enteropathy-Associated T-Cell Lymphoma | Recurrent Follicular T-Cell Lymphoma | Recurrent Hepatosplenic T-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
The Lymphoma Academic Research OrganisationCompletedHIV Infection | Stage III Adult Hodgkin Lymphoma | Stage IV Adult Hodgkin Lymphoma | HIV-associated Hodgkin LymphomaFrance
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage III Hodgkin Lymphoma | Ann Arbor Stage IIIA Hodgkin Lymphoma | Ann Arbor Stage IIIB Hodgkin Lymphoma | Ann Arbor Stage IV Hodgkin Lymphoma | Ann Arbor Stage IVA Hodgkin Lymphoma | Ann Arbor Stage IVB Hodgkin Lymphoma | Classic Hodgkin Lymphoma | Ann Arbor Stage IB Hodgkin Lymphoma | Ann... and other conditionsUnited States
-
University of WashingtonNational Cancer Institute (NCI)WithdrawnAnaplastic Large Cell Lymphoma, ALK-Positive | CD30-Positive Neoplastic Cells Present | Systemic Anaplastic Large Cell LymphomaUnited States
-
Seagen Inc.TerminatedLymphoma, Non-Hodgkin | Lymphoma, Large-Cell, Anaplastic | Disease, HodgkinUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRelapsed Classic Hodgkin LymphomaUnited States
-
John ReneauActive, not recruitingRecurrent T-Cell Non-Hodgkin Lymphoma | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma | Primary Cutaneous Anaplastic Large Cell Lymphoma | Refractory Primary Cutaneous T-Cell Non-Hodgkin... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Classic Hodgkin LymphomaUnited States
-
Fondazione Italiana Linfomi ONLUSCompleted
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedEverolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin LymphomaRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States